KeifeRx Receives FDA Approval of New Investigational Drug for Phase 3 Study of Nilotinib BE in Early Alzheimer’s Disease

WASHINGTON, July 20, 2021 / PRNewswire / – KeifeRx, LLC, an emerging clinical-stage biotechnology company specializing in the discovery and development of new treatment options for neurodegenerative diseases, today announced that the company has received acceptance of its application investigational new drug (IND) from the United States The United States …

Read More »

Automated Covid-19 Tests – A Pie In The Sky?

The ongoing fourth wave of the coronavirus has sharply increased the need for Covid-19 testing, prompting calls for the introduction of automation equipment. However, according to industry watchers, the lack of reagents for the automated installation will likely be a major stumbling block for automated testing. A health worker performs …

Read More »